MUSCULAR COUNTER PULSATION IN ACUTELY DECOMPENSATED HEART FAILURE

MUSCULAR COUNTER PULSATION IN ACUTELY DECOMPENSATED HEART FAILURE - MCP in HF

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON45215

Enrollment

Registered

2017-10-04

Start date

2016-08-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished pump function of the heart Heartfailure

Interventions

All patients will receive standard HF therapy as applied in all our patients being hospitalized with ADHF. Additionally, patients in the treatment group will be provided with an MCP device (m.pulse,

heartfailure

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: NYHA class III+ or IV on admission Clinical signs of cardiac decompensation are clearly present at inclusion into the study NT-pro BNP >800 pg/ml

Exclusion criteria

Exclusion criteria: Systolic BP >180mmHg (despite treatment) or

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the effect of MCP on the combination of the cumulative diuretic dosage and length of hospital stay due to decompensated heart failure	—

Secondary

Measure	Time frame
-	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)